Rory Collins

9.8k total citations · 3 hit papers
10 papers, 6.2k citations indexed

About

Rory Collins is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Economics and Econometrics. According to data from OpenAlex, Rory Collins has authored 10 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Economics and Econometrics. Recurrent topics in Rory Collins's work include Health Systems, Economic Evaluations, Quality of Life (3 papers), Meta-analysis and systematic reviews (2 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). Rory Collins is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (3 papers), Meta-analysis and systematic reviews (2 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). Rory Collins collaborates with scholars based in United Kingdom, China and Australia. Rory Collins's co-authors include Sarah Lewington, Gary Whitlock, Robert B. Clarke, Jonathan Emberson, Jim Halsey, Nawab Qizilbash, Paul Sherliker, Richárd Pető, Alison Scrimgeour and Salim Yusuf and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Epidemiology.

In The Last Decade

Rory Collins

10 papers receiving 5.9k citations

Hit Papers

Body-mass index and cause-specific mor... 1988 2026 2000 2013 2009 1988 2004 1000 2.0k 3.0k

Peers

Rory Collins
Thomas P. Erlinger United States
Patrick Commerford South Africa
Hugh Tunstall‐Pedoe United Kingdom
Nicolas Rodondi Switzerland
T W Meade United Kingdom
Caroline Morrison United Kingdom
Thomas P. Erlinger United States
Rory Collins
Citations per year, relative to Rory Collins Rory Collins (= 1×) peers Thomas P. Erlinger

Countries citing papers authored by Rory Collins

Since Specialization
Citations

This map shows the geographic impact of Rory Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rory Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rory Collins more than expected).

Fields of papers citing papers by Rory Collins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rory Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rory Collins. The network helps show where Rory Collins may publish in the future.

Co-authorship network of co-authors of Rory Collins

This figure shows the co-authorship network connecting the top 25 collaborators of Rory Collins. A scholar is included among the top collaborators of Rory Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rory Collins. Rory Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Smith, Margaret, Liming Li, Om Kurmi, et al.. (2014). Prevalence and correlates of airflow obstruction in ∼317 000 never-smokers in China. European Respiratory Journal. 44(1). 66–77. 52 indexed citations
2.
Whitlock, Gary, Sarah Lewington, Paul Sherliker, et al.. (2009). Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. The Lancet. 373(9669). 1083–1096. 3418 indexed citations breakdown →
3.
Mihaylova, Borislava, Andrew Briggs, Jane Armitage, et al.. (2005). Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20 536 individuals. The Lancet. 365(9473). 1779–1785. 86 indexed citations
4.
Collins, Rory, et al.. (2004). Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions. The Lancet. 363(9411). 757–767. 749 indexed citations breakdown →
5.
MacMahon, Stephen & Rory Collins. (2001). Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies. The Lancet. 357(9254). 455–462. 174 indexed citations
6.
Keavney, Bernard, Colin A. McKenzie, Sarah Parish, et al.. (2000). Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. The Lancet. 355(9202). 434–442. 284 indexed citations
7.
Sandercock, Peter, et al.. (1997). Hospital management of acute ischemic stroke in China. Journal of Stroke and Cerebrovascular Diseases. 6(5). 361–367. 34 indexed citations
8.
Collins, Rory, Richard Peto, Colin Baigent, & Peter Sleight. (1997). Aspirin, Heparin, and Fibrinolytic Therapy in Suspected Acute Myocardial Infarction. New England Journal of Medicine. 336(12). 847–860. 189 indexed citations
9.
Peto, Richard, Rory Collins, & Richard Gray. (1995). Large-scale randomized evidence: Large, simple trials and overviews of trials. Journal of Clinical Epidemiology. 48(1). 23–40. 234 indexed citations
10.
Collins, Rory, Alison Scrimgeour, Salim Yusuf, & Richárd Pető. (1988). Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous Heparin. New England Journal of Medicine. 318(18). 1162–1173. 981 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026